Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Other Working Capital Changes: 2017-2025

Historic Other Working Capital Changes for Arcus Biosciences (RCUS) over the last 9 years, with Sep 2025 value amounting to -$26.0 million.

  • Arcus Biosciences' Other Working Capital Changes fell 138.81% to -$26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$256.0 million, marking a year-over-year decrease of 725.81%. This contributed to the annual value of -$56.0 million for FY2024, which is 17.65% up from last year.
  • Arcus Biosciences' Other Working Capital Changes amounted to -$26.0 million in Q3 2025, which was up 83.75% from -$160.0 million recorded in Q2 2025.
  • Over the past 5 years, Arcus Biosciences' Other Working Capital Changes peaked at $67.0 million during Q3 2024, and registered a low of -$339.6 million during Q4 2021.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$28.0 million (2025), whereas its average is -$30.7 million.
  • As far as peak fluctuations go, Arcus Biosciences' Other Working Capital Changes plummeted by 308,842.73% in 2021, and later spiked by 309.38% in 2024.
  • Arcus Biosciences' Other Working Capital Changes (Quarterly) stood at -$339.6 million in 2021, then skyrocketed by 89.99% to -$34.0 million in 2022, then soared by 50.00% to -$17.0 million in 2023, then tumbled by 147.06% to -$42.0 million in 2024, then tumbled by 138.81% to -$26.0 million in 2025.
  • Its last three reported values are -$26.0 million in Q3 2025, -$160.0 million for Q2 2025, and -$28.0 million during Q1 2025.